Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

    Successful Therapy
    • SVR is defined as undetectable HCV RNA 24 weeks following treatment end
      • For patients treated with PI-containing regimens, SVR is specifically defined as HCV RNA < 25 IU/mL at Week 24 posttreatment
      • SVR at 12 weeks after completion of treatment has been adopted by drug approval bodies as a surrogate for SVR24
    Strategies to Reduce the Risk of Reinfection

    Action required